Measuring the performance of international genomics research projects in fostering genomic capacity in the developing world

References

• Ali-Khan, Sarah E., Tomasz Krakowski, Rabia Tahir, and Abdallah S. Daar. 2011. “The Use of Race, Ethnicity and Ancestry in Human Genetic Research.” The HUGO Journal 5: 47–63. doi:10.1007/s11568-011-9154-5.
   PubMedGoogle Scholar
• Barton, John H. 2002. “Research-tool Patents: Issues for Health in the Developing World.” Bulletin of the World Health Organization 80: 121.
   PubMed Web of Science ®Google Scholar
• Bhardwaj, Minakshi. 2012. “The Progress of Genomics in the Developing World: Rising Social, Economic, and Ethical Concerns.” In Genomics and Health in the Developing World, edited by Dhavendra Kumar, 90–102. Oxford: Oxford University Press.
   Google Scholar
• Bolnick, Deborah A. 2008. “Individual Ancestry Inference and the Reification of Race as a Biological Phenomenon.” In Revisiting Race in a Genomic Age, edited by Barbara A. Koenig, Sandra Soo-Jin Lee, and Sarah S. Richardson, 70–85. New Brunswick, NJ: Rutgers University Press.
   Google Scholar
• Brown, Stuart M., John G. Hay, and Harry Ostrer. 2008. Essentials of Medical Genomics. 2nd ed. Oxford: Wiley-Blackwell.
   Google Scholar
• Bubela, Tania, Garret A. FitzGerald, and Richard Gold. 2012. “Recalibrating Intellectual Property Rights to Enhance Translational Research Collaborations.” Science Translational Medicine 4: 122. doi:10.1126/scitranslmed.3003490.
   Web of Science ®Google Scholar
• Bustamante, Carlos D., Esteban Gonzalez Burchard, and Francisco M. De La Vega. 2011. “Genomics for the World.” Nature 475: 163–165. doi:10.1038/475163a.
   PubMed Web of Science ®Google Scholar
• CAHS (Canadian Academy of Health Sciences). 2009. Making an Impact: A Preferred Framework and Indicators to Measure Returns on Investment in Health Research. Ottawa: CAHS.
   Google Scholar
• Caulfield, Timothy, Stephanie M. Fullerton, Sarah E. Ali-Khan, Laura Arbour, Esteban G. Burchard, Richard S. Cooper, Billie-Jo Hardy, et al. 2009. “Race and Ancestry in Biomedical Research: Exploring the Challenges.” Genome Medicine 1: 8. doi:10.1186/gm8.
   PubMed Web of Science ®Google Scholar
• Clayton, Ellen Wright. 2003. “Ethical, Legal, and Social Implications of Genomic Medicine.” The New England Journal of Medicine 349: 562–569. doi: 10.1056/NEJMra012577
   PubMed Web of Science ®Google Scholar
• Colyvas, Jeannette, Michael Crow, Annetine Gelijns, Roberto Mazzoleni, Richard R. Nelson, Nathan Rosenberg, and Bhaven N. Sampat. 2002. “How Do University Inventions Get Into Practice.” Management Science 48: 61–72. doi: 10.1287/mnsc.48.1.61.14272
   Web of Science ®Google Scholar
• CST (Conseil de la science et de la technologie), Quebec. 2005. La Valorisation de la Recherche Universitaire: Clarification Conceptuelle. Sainte-Foy: Conseil de la science et de la technologie.
   Google Scholar
• Daar, Abdallah S., and Peter A. Singer. 2011. The Grandest Challenge: Bringing Life-saving Science from Lab to Village. Toronto: Doubleday Canada.
   Google Scholar
• Daar, Abdallah S., Halla Thorsteindottir, Douglas K. Martin, Alyna C. Smith, Shauna Nast, and Peter A. Singer. 2002. “Top Ten Biotechnologies for Improving Health in Developing Countries.” Nature Genetics 32: 229–232. doi: 10.1038/ng1002-229
   PubMed Web of Science ®Google Scholar
• De Jonge, Bram, and Niels Louwaars. 2009. “Valorizing Science: Whose Values?” EMBO Reports 10: 535–539. doi:10.1038/embor.2009.113.
   PubMed Web of Science ®Google Scholar
• De Vries, Jantina, Susan J. Bull, Ogobara Doumbo, Muntaser Ibrahim, Odile Mercereau-Puijalon, Dominic Kwiatkowski, and Michael Parker. 2011. “Ethical Issues in Human Genomics Research in Developing Countries.” BMC Medical Ethics 12: 356.
   Web of Science ®Google Scholar
• De Vries, Jantina, and Michael Pepper. 2012. “Genomic Sovereignty and the African Promise: Mining the African Genome for the Benefit of Africa.” Journal of Medical Ethics 38: 474–478. doi: 10.1136/medethics-2011-100448
   PubMed Web of Science ®Google Scholar
• Donovan, Claire, and Stephen Hanney. 2011. “The ‘Payback Framework’ Explained.” Research Evaluation 20: 181–183. doi: 10.3152/095820211X13118583635756
   Web of Science ®Google Scholar
• DRA (Dennis Rank and Associates). 2010. Evaluation of Genome British Columbia. Vancouver: Dennis Rank and Associates.
   Google Scholar
• E&Y (Ernst & Young). 2014. Beyond Border: Unlocking Value – Biotechnology Industry Report 2014. London: E&Y.
   Google Scholar
• Evans, James P., Eric M. Meslin, Theresa M. Marteau, and Timothy Caulfield. 2011. “Deflating the Genomic Bubble.” Science 331: 861–862. doi: 10.1126/science.1198039
   PubMed Web of Science ®Google Scholar
• Evans, Samantha. 2014a. “Evaluating Genomic Science: A Conversation with Dr. Samantha Evans.” University of British Columbia conference, Vancouver, May 21.
   Google Scholar
• Evans, Samantha. 2014b. Handout – Evaluating Genomic Science: A Conversation with Dr. Samatha Evans, Director of Evaluation, Genome Canada. Ottawa: Genome Canada.
   Google Scholar
• Gault, Fred, ed. 2013. Handbook of Innovation Indicators and Measurement. Cheltenham: Edward Elgar.
   Google Scholar
• Godin, Benoit, and Christian Dore. 2005. Measuring the Impact of Science: Beyond the Economic Dimension. Montreal: Institut national de la recherche scientifique.
   Google Scholar
• Gold, Richard, Warren Kaplan, James Orbinski, Sarah Harland-Logan, and Sevil N.-Marandi. 2010. “Are Patents Impeding Medical Care and Innovation?” PLoS Medicine 7: e1000208. doi:10.1371/journal.pmed.1000208.
   PubMed Web of Science ®Google Scholar
• Green, Eric D., Mark S. Guyer, and National Human Genome Research Institute. 2011. “Charting a Course for Genomic Medicine from Base Pairs to Bedside.” Nature 470: 204–213. doi:10.1038/nature09764.
   PubMed Web of Science ®Google Scholar
• GSK (GlaxoSmithKline). 2016. “GSK Expands Graduated Approach to Patents and Intellectual Property to Widen Access to Medicines in the World’s Poorest Countries.” Accessed May 12, 2016. http://www.gsk.com/en-gb/media/press-releases/2016/gsk-expands-graduated-approach-to-patents-and-intellectual-property-to-widen-access-to-medicines-in-the-world-s-poorest-countries/.
   Google Scholar
• Guebert, Jenilee M., and Tania Bubela. 2014. “Implementing Socially Responsible Licensing for Global Health: Beyond Neglected Diseases.” Science Translational Medicine 6: 260cm11. doi:10.1126/scitranslmed.3009422.
   PubMed Web of Science ®Google Scholar
• Hanney, Stephen R., Miguel A. Gonzalez Block, Martin J. Buxton, and Maurice Kogan. 2003. “The Utilization of Health Research in Policy-making: Concepts, Examples and Methods of Assessment.” Health Research Policy and Systems 1: 717. doi: 10.1186/1478-4505-1-2
   Google Scholar
• Hotez, Peter, Rachel Cohen, Carol Mimura, Tadataka Yamada, and Stephen L. Hoffman. 2013. Strengthening Mechanisms to Prioritize, Coordinate, Finance, and Execute R&D to Meet Health Needs in Developing Countries. Washington, DC: Institute of Medicine of the National Academies.
   Google Scholar
• IMF (International Monetary Fund). 2014. World Economic Outlook. Washington, DC: IMF.
   Google Scholar
• Ioannidis, John P. A., and Muin J. Khoury. 2014. “Assessing Value in Biomedical Research: The PQRST of Appraisal and Reward.” Journal of the American Medical Association 312: 483. doi:10.1001/jama.2014.6932.
   Web of Science ®Google Scholar
• Jasanoff, Sheila. 2004. “Ordering Knowledge, Ordering Society.” In States of Knowledge: The Co-production of Science and Social Order, edited by Sheila Jasanoff, 13–45. London: Routledge.
   Google Scholar
• Joly, Yann. 2010. “Open Biotechnology: Licenses Needed.” Nature Biotechnology 28: 417–419. doi:10.1038/nbt0510-417.
   PubMed Web of Science ®Google Scholar
• Joly, Yann. 2012. “Le rôle des modèles ouverts dans la valorisation de la recherche biomédicale.” Département de physiologie-biophysique de l’Université de Sherbrooke conference, Sherbrooke, May 17.
   Google Scholar
• Joly, Yann, Clarissa Allen, and Bartha Maria Knoppers. 2012. “Open Access as Benefit Sharing? The Example of Publicly Funded Large-scale Genomic Databases.” Journal of Law, Medicine & Ethics 40: 143–146. doi:10.1111/j.1748-720X.2012.00652.x.
   PubMedGoogle Scholar
• Joly, Yann, Angus Livingstone, and Edward S. Dove. 2012. Moving Beyond Commercialization: Strategies to Maximize the Economic and Social Impact of Genomics Research. Ottawa: Genome Canada.
   Google Scholar
• Joshi, Kalpana, Yogita Ghodke, and Pooja Shintre. 2010. “Traditional Medicine and Genomics.” Journal of Ayurveda and Integrative Medicine 1: 26. doi: 10.4103/0975-9476.59824
   PubMedGoogle Scholar
• Kleinert, Sabine, and Richard Horton. 2014. “How Should Medical Science Change?” The Lancet 383: 197–198. doi:10.1016/S0140-6736(13)62678-1.
   PubMed Web of Science ®Google Scholar
• Knoppers, Bartha M. 2013. “Genomics: From Persons to Populations and Back Again.” Genome 56: 537–539. doi:10.1139/gen-2013-0148.
   PubMed Web of Science ®Google Scholar
• Koutouki, Konstantia. 2010. “A Legal Placebo: The Role of International Patent Law in the Protection of Indigenous Traditional Knowledge of Medicinal Plants.” Canadian Intellectual Property Review 26: 19.
   Google Scholar
• KPMG. 2009. Evaluation of Genome Canada – Final Report. Ottawa: KPMG.
   Google Scholar
• Krol, Aaron. 2014. “What You Need to Know about Illumina’s New Sequencers.” Bio-IT World, January 15. Accessed November 26, 2014. http://www.bio-itworld.com/2014/1/15/what-you-need-know-about-illuminas-new-sequencers.html.
   Google Scholar
• Kumar, Dhavendra. 2012. “Transcultural Perspectives on Genetics and Genomics.” In Genomics and Health in the Developing World, edited by Dhavendra Kumar, 66–72. Oxford: Oxford University Press.
   Google Scholar
• Langford, Cooper H., Jeremy Hall, Peter Josty, Stelvia Matos, and Astrid Jacobson. 2006. “Indicators and Outcomes of Canadian University Research: Proxies Becoming Goals?” Research Policy 35: 1586–1598. doi: 10.1016/j.respol.2006.09.021
   Web of Science ®Google Scholar
• Macleod, Malcolm R., Susan Michie, Ian Roberts, Ulrich Dirnagl, Iain Chalmers, John P. A. Ioannidis, Rustam Al-Shahi Salman, An-Wen Chan, and Paul Glasziou. 2014. “Biomedical Research: Increasing Value, Reducing Waste.” The Lancet 383: 101–104. doi:10.1016/S0140-6736(13)62329-6.
   PubMed Web of Science ®Google Scholar
• McCarty, Jeanette J., Howard L. McLeod, and Geoffrey S. Ginburg. 2013. “Genomic Medicine: A Decade of Successes, Challenges and Opportunities.” Science Translational Medicine 5: 189sr4. doi:10.1126/scitranslmed.3005785.
   PubMed Web of Science ®Google Scholar
• McGuire, Amy L., Steven Joffe, Barbara A. Koenig, Barbara B. Biesecker, Laurence B. McCullough, Jennifer S. Blumenthal-Barby, Timothy Caulfied, Sharon F. Terry, and Robert C. Green. 2013. “Ethics and Genomic Incidental Findings.” Science 340: 1047–1048. doi: 10.1126/science.1240156
   PubMed Web of Science ®Google Scholar
• Mimura, Carol. 2010. “Nuanced Management of IP Rights: Shaping Industry-university Relationships to Promote Social Impact.” In Working Within the Boundaries of Intellectual Property: Innovation Policy for the Knowledge Society, edited by Rochelle C. Dreyfuss, Diane L. Zimmerman, and Harry First, 293–304. Oxford: Oxford University Press.
   Google Scholar
• Moon, Suerie, George Bermude, and Ellen’T Hoen. 2012. “Innovation and Access to Medicines for Neglected Populations: Could a Treaty Address a Broken Pharmaceutical R&D System?” PLoS Medicine 9: e1001218. doi:10.1371/journal.pmed.1001218.
   PubMed Web of Science ®Google Scholar
• Mowery, David C., Richard R. Nelson, Bhaven N. Sampat, and Arvids A. Ziedonis. 2004. Ivory Tower and Industrial Innovation: University-industry Technology Transfer Before and After the Bayh-Dole Act. Stanford, CA: Stanford University Press.
   Google Scholar
• MRC (Medical Research Council). 2016. Outputs, Outcome and Impact of MRC Research: 2014/2015 Report. London: MRC.
   Google Scholar
• MUGQIC (McGill University and Genome Quebec Innovation Centre). n.d. “Illumina HiSeq and MiSeq Technologies.” Accessed November 28, 2014. http://gqinnovationcenter.com/services/sequencing/technoMPSIlluminaHiSeq.aspx?l=f.
   Google Scholar
• NHGRI (National Human Genome Research Institute). n.d. DNA Sequencing Costs. NHGRI. Accessed November 28, 2014. http://www.genome.gov/sequencingcosts/.
   Google Scholar
• NIH (National Institutes of Health). 2016. NIH and Other PHS Agency Research Performance Progress Report (RPPR) Instruction Guide. Bethesda, MD: NIH.
   Google Scholar
• OECD (Organisation for Economic Co-operation and Development). 2005. Oslo Manual: Guidelines for Collecting and Interpreting Innovation Data. 3rd ed. Paris: OECD.
   Google Scholar
• OECD (Organisation for Economic Co-operation and Development). 2008. Open Innovation in a Global Perspective – What Do Existing Data Tell Us? Paris: OECD.
   Google Scholar
• OECD (Organisation for Economic Co-operation and Development). 2013. Measuring Patent Quality: Indicators of Technological and Economic Value. Paris: OECD.
   Google Scholar
• Pang, Tikki. 2012. “Infections, Genomics and Global Public Health.” In Genomics and Health in the Developing World, edited by Dhavendra Kumar, 152–156. Oxford: Oxford University Press.
   Google Scholar
• Pang, Tikki, and David Weatherall. 2012. “Genomics and World Health: A Decade on.” The Lancet 379: 1853–1854. doi:10.1016/S0140-6736(12)60562-5.
   PubMed Web of Science ®Google Scholar
• Panofsky, Aaron, and Catherine Bliss. 2017. “Ambiguity and Scientific Authority: Population Classification in Genomic Science.” American Sociological Review 82: 59–87. doi:10.1177/0003122416685812.
   Web of Science ®Google Scholar
• Ramsay, Michele, Jantina De Vries, Himla Soodyall, Shane A. Norris, and Osman Sankoh, as Members of the H3Africa Consortium. 2014. “Ethical Issues in Genomic Research on the African Continent: Experiences and Challenges to Ethics Review Committees.” Human Genomics 8: 15. doi: 10.1186/s40246-014-0015-x
   PubMed Web of Science ®Google Scholar
• Rank, Dennis. 2009. “Measuring the Impacts of Science and Technology.” Canadian Association of Research Administrators, conference, Ottawa, December 17.
   Google Scholar
• Reardon, Jenny. 2005. Race to the Finish: Identity and Governance in an Age of Genomics. Princeton, NJ: Princeton University Press.
   Google Scholar
• Reardon, Jenny. 2008. “Race Without Salvation: Beyond the Science/Society Divide in Genomic Studies of Human Diversity.” In Revisiting Race in a Genomic Age, edited by Barbara A. Koenig, Sandra Soo-Jin Lee, and Sarah S. Richardson, 304–319. New Brunswick, NJ: Rutgers University Press.
   Google Scholar
• Rotimi, Charles. 2014. “H3Africa: Human Heredity and Health in Africa.” Conference to eliminate heath disparities in genomic medicine, the role of policy, Washington, DC, September 4–5.
   Google Scholar
• Rotimi, Charles, and Lynn Jorde. 2012. “Ancestry, Disease and Variable Drug Response in the Genomic Era.” In Genomics and Health in the Developing World, edited by Dhavendra Kumar, 47–54. Oxford: Oxford University Press.
   Google Scholar
• Salman, Rustam Al-Shahi, Elaine Beller, Jonathan Kagan, Elina Hemminki, Robert S. Phillips, Julian Savulescu, Malcolm Macleod, Janet Wisely, and Iain Chalmers. 2014. “Increasing Value and Reducing Waste in Biomedical Research Regulation and Management.” The Lancet 383: 176–185. doi:10.1016/S0140-6736(13)62297-7.
   PubMed Web of Science ®Google Scholar
• Sampogna, Christina. 2008. Collaborative Mechanisms for IPR Management: Theory & Practice. Stockholm Network Workshop. Paris: Organisation for Economic Co-operation and Development, September 22.
   Google Scholar
• Sboner, Andra, Xinmeng Jasmine Mu, Dov Greenbaum, Raymond K. Auerbach, and Mark B. Gerstein. 2011. “The Real Cost of Sequencing: Higher Than you Think!” Genome Biology 12: 125. doi:10.1186/gb-2011-12-8-125.
   PubMed Web of Science ®Google Scholar
• Séguin, Béatrice, Billie-Jo Hardy, Peter A. Singer, and Abdallah S. Daar. 2008. “Genomic Medicine and Developing Countries: Creating a Room of Their own.” Nature Reviews Genetics 9: 487–493. doi:10.1038/nrg2379.
   PubMed Web of Science ®Google Scholar
• Seung, Sebastian. 2012. Connectome. Boston, MA: Houghton Mifflin Harcourt.
   Google Scholar
• Singer, Peter A., Archana Bhatt, Sarah Frew, Heather Greenwood, Deepa L. Persad, Fabio Salamanca-Buentello, Béatrice Séguin, Andrew D. Taylor, Halla Thorsteindottir, and Abdallah S. Daar. 2005. “The Critical Role of Genomics in Global Health.” Global Forum Update on Research for Health 2: 113.
   Google Scholar
• Smith, Richard D., Halla Thorsteindottir, Abdallah S. Daar, Richard Gold, and Peter A. Singer. 2004. “Genomics Knowledge and Equity: A Global Public Goods Perspective of the Patent System.” Bulletin of the World Health Organization 82: 385.
   PubMed Web of Science ®Google Scholar
• STIC (Science, Technology and Innovation Council). 2012. State of the Nation 2012 – Canada’s Science, Technology and Innovation System: Aspiring to Global Leadership. Ottawa: STIC.
   Google Scholar
• TIP (The Innovation Partnership), International Expert Group on Biotechnology, Innovation and Intellectual Property. 2008a. Toward a New Era of Intellectual Property: From Confrontation to Negotiation. Montreal: TIP.
   Google Scholar
• TIP (The Innovation Partnership), International Expert Group on Biotechnology, Innovation and Intellectual Property. 2008b. Designing Metrics to Assess the Impacts and Social Benefits of Publicly Funded Research in Health and Agricultural Biotechnology. Montreal: TIP.
   Google Scholar
• TR (Thomson Reuters). n.d. Web of Science. TR. Accessed April 7, 2016. http://ipscience.thomsonreuters.com/product/web-of-science/?utm_source=false&utm_medium=false&utm_campaign=false.
   Google Scholar
• UNICEF (United Nations Children’s Fund). 2014. Generation 2030/Africa: Child Demographics in Africa. New York: UNICEF.
   Google Scholar
• UNMPSTTF (United Nations Millennium Project Science and Technology Task Force), Genomics Working Group. 2004. Genomics and Global Health. Toronto: University of Toronto Joint Centre for Bioethics.
   Google Scholar
• Ward, Derek J., Angharad Slade, Tracey Genus, Orsolina I. Martino, and Andrew J. Stevens. 2014. “How Innovative Are New Drugs Launched in the UK? A Retrospective Study of New Drugs Listed in the British National Formulary (BNF) 2001–2012.” BMJ Open 4: e006235. doi:10.1136/bmjopen-2014-006235.
   PubMed Web of Science ®Google Scholar
• WHO (World Health Organization). 2002. Genomics and World Health. Geneva: WHO.
   Google Scholar
• WHO (World Health Organization). n.d. Genomics and the Global Health Divide. WHO. Accessed April 7, 2014. http://www.who.int/genomics/healthdivide/en/.
   Google Scholar
• WHO (World Health Organization). 2015. Investing to Overcome the Global Impact of Neglected Tropical Diseases. Geneva: WHO.
   Google Scholar
• Williams-Jones, Bryn, and Oonagh P. Corrigan. 2003. “Rhetoric and Hype: Where’s the ‘Ethics’ in Pharmacogenomics.” American Journal of Pharmacogenomics 3: 375–383. doi: 10.2165/00129785-200303060-00004
   PubMedGoogle Scholar
• Yun, Hong-Min, Manshu Song, and Wei Wang. 2012. “Traditional Chinese Medicine in the Area of Genomics.” In Genomics and Health in the Developing World, edited by Dhavendra Kumar, 842–845. Oxford: Oxford University Press.
   Google Scholar